Search for: "ABBOTT v. ABBOTT"
Results 1421 - 1440
of 2,570
Sorted by Relevance
|
Sort by Date
7 Jun 2011, 8:58 am
Filed May 31, 2011, by Abbott Diabetes Care. (5) 90/011,721 (electronically filed) - U.S. [read post]
3 Dec 2010, 5:11 am
Abbott and DexCom spared in reexamination over that technology in the past, for instance regarding U.S. [read post]
3 Dec 2010, 5:11 am
Abbott and DexCom spared in reexamination over that technology in the past, for instance regarding U.S. [read post]
29 May 2012, 8:17 am
See Schaefer-LaRose v. [read post]
7 Feb 2018, 2:53 am
[v] This number increased from 49% after Abbott’s 2017 acquisition of major competitor Alere. [read post]
24 Oct 2018, 9:16 am
Abbott Labs., 636 F.3d1341, 1348 (Fed. [read post]
3 Feb 2010, 2:00 am
Barr Laboratories, Inc. and Mylan Pharma (Patent Docs) (Patently-O) Omnicef (Cefdinir) – US: CAFC on whether a product-by-process claim is infringed by an identical product made by different process: Abbott Labs v Sandoz (IP Frontline) Pertussis vaccines – UK: EWHC dismisses Medeva appeal against pertussis vaccines SPCs refusal (The SPC Blog) Plavix (Clopidogrel) – Canada: Adding some obvious flexibility: Apotex Inc v Sanofi-Synthelabo Canada Inc (IP… [read post]
30 Nov 2009, 12:33 am
" PDK Labs., Inc. v. [read post]
22 Apr 2016, 7:57 am
In The Daily Signal, Josh Siegel reports on comments by Texas governor Greg Abbott, who predicts that the Court will deadlock in the case. [read post]
20 Jul 2010, 7:35 am
Monday, Oct. 4: Abbott v. [read post]
4 Mar 2021, 10:13 am
See Abbott, 560 U.S. at 10–11. [read post]
19 Feb 2010, 4:00 pm
Abbott, AG, No. 07-0931 (Tex. [read post]
25 Jan 2007, 12:24 am
Hevesi, respondent
NEW YORK COUNTYPersonal PropertyUntimely Mechanic's Lien Discharged; Lien Notice Required Within Four Months in Single Dwelling Matter of Abbott v. [read post]
24 Jan 2007, 12:34 am
Hevesi, respondent
NEW YORK COUNTYPersonal PropertyUntimely Mechanic's Lien Discharged; Lien Notice Required Within Four Months in Single Dwelling Matter of Abbott v. [read post]
1 Mar 2011, 8:38 pm
Highlights this week included: Humira (Adalimumab) – US: $1.67B verdict overturned by CAFC, patent invalidated over written description: Centocor v Abbott (Peter Zura’s 271 Patent Blog) (Patently-O) (Patently-O) (Patent Law Practice Center) (Patent Docs) (IPBiz) Fexofenadine – Australia: Anti-histamine inventive… but not novel, says Federal Court! [read post]
10 Jun 2009, 5:00 am
: Abbott v Sandoz (Patent Baristas) (FDA Law Blog) (Patents4Life) Optimum GAT corn – US: BASF Plant Science files patent infringement suit against Pioneer Hi-Bred International based on its sale of Optimum GAT corn; Pioneer countersues for patent infringement and declaratory judgment of non-infringement and patent invalidity (Patent Docs) Oracea (Doxycycline) – US: Galderma submits new QI Act 30-month stay citizen petition; a new variation on an old theme (FDA… [read post]
22 Mar 2011, 4:21 pm
: Board of Trustees of Leland Stanford Junior University v Roche Molecular Systems Inc (IPKat) US: That was unexpectedly… well… expected: BPAI affirms Examiner’s obviousness rejection in Ex Parte Akio Ochiai concerning a health food product containing curcumin, scymnol and isoflavones (BT-IP Notes) US: VirginiaTech VERSUS series – Drug evaluation DVDs available (FDA Law Blog) Products Diovan HCT (Valsartan, Hydrochlorothiazide) – Germany:… [read post]
11 Jan 2011, 11:07 pm
Highlights this week included: US: CAFC : Single embodiment commercial success: In re Glatt Air Techniques (Patently-O) (Patents Post Grant Blog) (PharmaPatents) (IPBiz) US: Reverse payment settlements return to the Supreme Court: Louisiana Wholesale Drug Co et al v Bayer et al (Patently-O) (FDA Law Blog) Kaletra (Ritonavir, Lopinavir) – India: Abbott’s patent on AIDS medicine denied (IP Watch) (Spicy IP) (SiNApSE) Please join the discussion by adding your comments on… [read post]
10 Jun 2009, 5:00 am
: Abbott v Sandoz (Patent Baristas) (FDA Law Blog) (Patents4Life) Optimum GAT corn – US: BASF Plant Science files patent infringement suit against Pioneer Hi-Bred International based on its sale of Optimum GAT corn; Pioneer countersues for patent infringement and declaratory judgment of non-infringement and patent invalidity (Patent Docs) Oracea (Doxycycline) – US: Galderma submits new QI Act 30-month stay citizen petition; a new variation on an old theme (FDA… [read post]
27 Oct 2016, 9:20 am
Alaska Oil & Gas Assn. v. [read post]
